Start Date
December 31, 2018
Primary Completion Date
May 31, 2019
Study Completion Date
August 31, 2021
NKR-2 CAR-T Cells
"The treatment consists in six consecutive cycles of AZA, administered at days~1 to 7 of a 28-day cycle. Patients will be treated with 8 injections of NKR-2 at day 9 and 23 of AZA cycles 2-3-4 and 5."
Lead Sponsor
Celyad Oncology SA
INDUSTRY